CardioVascular Disease Progression and Prognosis in COVID-19

The CVP-COVID19 registry is both a retrospective and prospective study design in order toidentify predictors of cardiovascular disease progression and mortality for COVID-19. Theregistry enrolls consecutive patients with positive microbiological tests for SARS-CoV-2admitted to an academic hospital in northern Italy for worsening of COVID-19 symptoms.The study does not test any new diagnostic or therapeutic approach. Patients are treatedaccording to good clinical practice. Patients characteristics, including medical history(with particular attention to cardiovascular and pneumological risk factors), features ofphysical examination, results laboratory and radiological tests and treatments (pre- andin-hospital) are related with patient outcome. Logistic analysis (univariate,multivariate and propensity) are performed in order to identify factors associated withdisease progression. Primary endpoint: mortality.